We demonstrated that diacerein has a beneficial effect by attenuating the clinical severity, reducing the disease-associated splenomegaly, and decreasing the infiltration of lymphoid CD11c+ DCs to the spleen and myeloid CD11c+ DCs to the skin in an IMQ-induced psoriasis mouse model. The gene discussed is ITGAX; the disease is Splenomegaly.